Article info
Research letter
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
- Correspondence to Dr Harpreet K Lota, Interstitial Lung Disease Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; h.lota{at}rbht.nhs.uk
Citation
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
Publication history
- Received January 15, 2013
- Revised February 19, 2013
- Accepted February 21, 2013
- First published March 20, 2013.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions